
  
    
      
        Background_NNP
        In_IN skeletal_NN muscle_NN ,_, the_DT dihydropyridine_NN receptor_NN (_( DHPR_NNP )_)
        consists_VBZ of_IN α_NN 
        1_CD S_NNP ,_, α_NN 
        2_CD -_: δ_NN ,_, β_NN 
        1_CD a_DT and_NN γ_NN 
        1_CD subunits_NNS [_NN 1_CD ]_NN ._. This_DT complex_NN is_VBZ
        responsible_JJ for_IN the_DT L-_NNP type_NN Ca_MD 2_CD +_NN current_JJ and_CC serves_VBZ as_IN the_DT
        voltage_NN sensor_NN for_IN excitation-contraction_JJ (_( EC_NNP )_) coupling_NN ._. In_IN
        the_DT latter_JJ process_NN ,_, the_DT movement_NN of_IN electrical_JJ charges_NNS in_IN
        the_DT α_NN 
        1_CD S_NNP subunit_NN promotes_VBZ a_DT conformational_NN
        change_NN that_WDT opens_VBZ the_DT ryanodine_NN receptor_NN type-_NN 1_CD (_( RyR_NNP 1_LS )_) in_IN
        the_DT sarcoplasmic_JJ reticulum_NN membrane_NN (_( SR_NNP )_) leading_VBG to_TO an_DT
        increase_NN in_IN cytosolic_JJ Ca_MD 2_CD +_NN [_NN 2_CD ,_, 3_CD ]_NN ._. The_DT functional_JJ
        interactions_NNS between_IN the_DT DHPR_NNP subunits_NNS necessary_JJ for_IN
        opening_VBG the_DT Ca_MD 2_CD +_NN channel_NN are_VBP only_RB partially_RB known_VBN ._. Further_RB ,_,
        the_DT interactions_NNS between_IN DHPR_NNP subunits_NNS and_CC RyR_NNP 1_CD also_RB are_VBP
        incompletely_RB understood_VBN ._. The_DT α_NN 
        1_CD subunit_NN is_VBZ a_DT large_JJ protein_NN that_WDT
        contains_VBZ the_DT basic_JJ functional_JJ elements_NNS of_IN the_DT L-_NNP type_NN Ca_MD
        2_CD +_NN channel_NN ,_, including_VBG the_DT Ca_MD 2_CD +_NN selectivity_NN ,_,
        voltage-dependent_JJ gating_VBG ,_, and_CC sensitivity_NN to_TO
        dihydropyridines_NNS ._. The_DT cytoplasmic_JJ loop_NN between_IN repeats_VBZ II_NNP
        and_CC III_NNP of_IN the_DT α_NN 
        1_CD S_NNP subunit_NN interacts_NNS closely_RB with_IN RyR_NNP 1_CD
        and_CC is_VBZ an_DT important_JJ determinant_NN of_IN skeletal_NN type_NN EC_NNP
        coupling_NN [_NN 4_CD ,_, 5_CD ]_NN ._. A_DT region_NN in_IN the_DT cytoplasmic_JJ loop_NN between_IN
        repeats_VBZ I_PRP and_CC II_NNP of_IN the_DT α_NN 
        1_CD subunit_NN ,_, referred_VBD to_TO as_IN the_DT AID_NNP [_NN 6_CD ]_NN ,_,
        binds_NNS tightly_RB with_IN a_DT 30_CD amino_JJ acid_NN region_NN on_IN the_DT β_NN 
        1_CD subunit_NN ,_, referred_VBD to_TO as_IN the_DT BID_NNP [_NN 7_CD ]_NN ._.
        β_NN subunits_NNS are_VBP ∼_NN 55_CD to_TO 65_CD kDa_NN proteins_NNS essential_JJ for_IN
        channel_NN assembly_NN and_CC /_NN or_CC membrane_NN targeting_VBG ,_, as_RB well_RB as_IN for_IN
        modulation_NN of_IN channel_NN kinetics_NNS [_NN 8_CD ]_NN ._. The_DT α_NN 
        2_CD -_: δ_NN subunit_NN is_VBZ a_DT highly_RB glycosylated_JJ ∼_NN
        175_CD kDa_NN protein_NN formed_VBN by_IN two_CD disulfide-linked_JJ peptides_NNS
        encoded_JJ by_IN the_DT same_JJ gene_NN ._. Transmembrane_NNP topology_NN and_CC
        functional_JJ analyses_NNS suggest_VBP the_DT α_NN 
        2_CD -_: δ_NN subunit_NN is_VBZ composed_VBN of_IN a_DT single_JJ
        transmembrane_NN domain_NN and_CC a_DT short_JJ cytoplasmic_JJ tail_NN of_IN only_RB
        five_CD residues_NNS [_NN 9_CD ,_, 10_CD ]_NN ._. Given_VBN this_DT topology_NN ,_, the_DT α_NN 
        2_CD -_: δ_NN subunit_NN is_VBZ most_RBS likely_JJ to_TO interact_NN
        with_IN the_DT α_NN 
        1_CD and_CC /_NN or_CC the_DT γ_NN 
        1_CD subunits_NNS ._. The_DT γ_NN 
        1_CD subunit_NN is_VBZ a_DT ∼_NN 32_CD kDa_NN skeletal_NN
        muscle-specific_JJ protein_NN with_IN four_CD presumptive_JJ transmembrane_NN
        domains_NNS [_NN 11_CD ,_, 12_CD ,_, 13_CD ]_NN ._. The_DT transmembrane_NN topology_NN of_IN the_DT γ_NN 
        1_CD subunit_NN and_CC the_DT critical_JJ binding_JJ
        domains_NNS are_VBP unknown_JJ at_IN this_DT time_NN ._.
        EC_NNP coupling_NN is_VBZ initiated_VBN by_IN voltage-dependent_JJ charge_NN
        movements_NNS in_IN the_DT S_NNP 4_CD segments_NNS of_IN the_DT DHPR_NNP α_NN 
        1_CD S_NNP subunit_NN ,_, whose_WP$ expression_NN is_VBZ
        dependent_JJ on_IN the_DT presence_NN of_IN the_DT β_NN 
        1_CD a_DT subunit_NN [_NN 14_CD ]_NN ._. The_DT C-_NNP terminus_JJ of_IN the_DT
        β_NN 
        1_CD a_DT subunit_NN has_VBZ also_RB been_VBN shown_VBN to_TO be_VB
        important_JJ in_IN EC_NNP coupling_NN ,_, presumably_RB by_IN interaction_NN with_IN
        RyR_NNP 1_CD [_NN 15_CD ]_NN ._. The_DT role_NN of_IN the_DT α_NN 
        2_CD -_: δ_NN subunit_NN on_IN skeletal_NN EC_NNP coupling_NN is_VBZ
        unknown_JJ ,_, but_CC in_IN heterologous_JJ expression_NN systems_NNS it_PRP has_VBZ been_VBN
        demonstrated_VBN to_TO increase_VB the_DT amount_NN of_IN charge_NN movement_NN [_NN
        16_CD ]_NN ._. The_DT role_NN of_IN the_DT γ_NN 
        1_CD subunit_NN in_IN Ca_MD 2_CD +_NN channel_NN function_NN is_VBZ of_IN
        particular_JJ interest_NN given_VBN the_DT discovery_NN of_IN a_DT second_JJ γ_NN
        subunit_NN ,_, γ_NN 
        2_CD or_CC 
        stargazin_NN ,_, which_WDT is_VBZ expressed_VBN in_IN
        neurons_NNS and_CC is_VBZ responsible_JJ for_IN the_DT 
        stargazer_NN mutation_NN in_IN mice_NNS [_NN 17_CD ]_NN ._.
        Subsequently_RB ,_, several_JJ other_JJ γ_NN subunit_NN genes_NNS have_VBP been_VBN
        identified_VBN and_CC shown_VBN to_TO be_VB expressed_VBN in_IN brain_NN and_CC
        peripheral_JJ tissues_NNS [_NN 18_CD ,_, 19_CD ]_NN ._. In_IN the_DT present_JJ study_NN we_PRP
        examined_VBD the_DT role_NN of_IN the_DT γ_NN 
        1_CD subunit_NN in_IN L-_NNP type_NN Ca_MD 2_CD +_NN current_JJ and_CC EC_NNP
        coupling_NN in_IN skeletal_NN myotubes_NNS ._. Absence_NNP of_IN the_DT γ_NN 
        1_CD subunit_NN slows_VBZ inactivation_NN and_CC
        produces_VBZ a_DT depolarizing_VBG shift_NN in_IN the_DT Ca_MD 2_CD +_NN current_JJ
        inactivation_NN vs_NNS ._. voltage_NN curve_NN ,_, in_IN agreement_NN with_IN results_NNS
        from_IN an_DT independently_RB produced_VBN γ_NN 
        1_CD knockout_NN mouse_NN [_NN 20_CD ]_NN ._. However_RB ,_, absence_NN
        of_IN γ_NN 
        1_CD does_VBZ not_RB affect_VB the_DT voltage_NN dependence_NN
        or_CC the_DT magnitude_NN of_IN charge_NN movements_NNS and_CC Ca_MD 2_CD +_NN transients_NNS ._.
        Overall_RB ,_, the_DT γ_NN 
        1_CD subunit_NN appears_VBZ to_TO promote_VB inhibition_NN
        of_IN the_DT Ca_MD 2_CD +_NN channel_NN function_NN of_IN the_DT skeletal_NN DHPR_NNP ._. While_IN
        this_DT subunit_NN is_VBZ clearly_RB non-essential_JJ for_IN activation_NN of_IN the_DT
        L-_NNP type_NN Ca_MD 2_CD +_NN channel_NN and_CC for_IN triggering_VBG skeletal-type_JJ EC_NNP
        coupling_NN ,_, γ_NN 
        1_CD appears_VBZ to_TO specifically_RB modulate_VBP the_DT
        Ca_MD 2_CD +_NN channel_NN function_NN of_IN the_DT skeletal_NN DHPR_NNP ._.
      
      
        Results_NNS and_CC Discussion_NNP
        
          Inactivation_NNP of_IN the_DT DHPR_NNP γ_NN 1_CD subunit_NN by_IN gene_NN
          targeting_VBG
          Gene_NNP targeting_VBG was_VBD used_VBN to_TO replace_VB the_DT entire_JJ coding_VBG
          region_NN of_IN the_DT γ_NN 
          1_CD gene_NN with_IN the_DT 
          neo_NN gene_NN ,_, as_IN described_VBN in_IN Materials_NNPS
          and_CC Methods_NNP (_( Fig_NNP ._. 1_LS )_) ._. Targeted_NNP ES_NNP cell_NN clones_NNS were_VBD
          injected_VBN into_IN C_NNP 57_CD Bl_NNP /_NN 6_CD J_NNP blastocysts_NNS and_CC chimeras_NNS obtained_VBN ._.
          After_IN additional_JJ breeding_NN ,_, a_DT line_NN containing_VBG the_DT γ_NN 
          1_CD targeted_VBN allele_NN was_VBD obtained_VBN ._. Fig_NNP ._.
          1_LS Ashows_NNP Southern_NNP blots_NNS from_IN DNA_NNP of_IN control_NN (_( +_NN /_NN +_NN )_) ,_, γ_NN 
          1_CD het_NN (_( +_NN /_NN -_: )_) and_CC γ_NN 
          1_CD null_NN (_( -_: /_NN -_: )_) mice_NNS ,_, after_IN digestion_NN
          with_IN 
          Eco_NNP RI_NNP and_CC hybridization_NN to_TO probe_VB
          1_CD ._. The_DT γ_NN 
          1_CD het_NN and_CC γ_NN 
          1_CD null_NN mice_NNS show_VBP the_DT predicted_VBD 12_CD ._. 5_LS kb_NN
          restriction_NN fragment_NN indicative_JJ of_IN the_DT targeted_VBN allele_NN
          (_( Fig_NNP ._. 1_LS B_NNP )_) ._. Similarly_RB for_IN the_DT Southern_NNP blot_NN of_IN DNA_NNP
          digested_VBN with_IN 
          Hind_NNP III_NNP and_CC hybridized_JJ to_TO probe_VB 2_CD ,_,
          the_DT γ_NN 
          1_CD het_NN and_CC γ_NN 
          1_CD null_NN mice_NNS show_VBP the_DT predicted_VBD 3_CD ._. 5_CD kb_NN
          restriction_NN fragment_NN indicative_JJ of_IN the_DT targeted_VBN allele_NN
          (_( Fig_NNP ._. 1_LS C_NNP )_) ._. The_DT γ_NN 
          1_CD het_NN and_CC γ_NN 
          1_CD null_NN mice_NNS have_VBP no_DT visible_JJ
          abnormalities_NNS and_CC are_VBP fertile_JJ ._. Western_JJ blots_NNS showing_VBG the_DT
          expression_NN of_IN the_DT DHPR_NNP subunits_NNS are_VBP shown_VBN in_IN Fig_NNP 1_CD D_NNP ._. The_DT
          amount_NN of_IN the_DT γ_NN 
          1_CD subunit_NN present_JJ in_IN control_NN ,_, γ_NN 
          1_CD het_NN and_CC γ_NN 
          1_CD null_NN samples_NNS as_IN a_DT function_NN of_IN total_JJ
          membrane_NN protein_NN was_VBD determined_VBN in_IN two_CD independent_JJ
          membrane_NN preparations_NNS ._. These_DT data_NNS indicate_VBP that_IN the_DT
          amount_NN of_IN γ_NN 
          1_CD expression_NN in_IN membranes_NNS from_IN γ_NN 
          1_CD null_NN muscle_NN was_VBD not_RB detectable_JJ above_IN
          background_NN (_( no_DT primary_NN antibody_NN )_) as_IN expected_VBN from_IN the_DT
          fact_NN that_IN the_DT entire_JJ gene_NN was_VBD deleted_VBN ._. In_IN membranes_NNS
          isolated_VBN from_IN the_DT γ_NN 
          1_CD het_NN mice_NNS ,_, the_DT level_NN of_IN expression_NN of_IN
          the_DT γ_NN 
          1_CD subunit_NN was_VBD 64_CD %_NN of_IN control_NN values_NNS
          for_IN each_DT of_IN the_DT two_CD independent_JJ determinations_NNS ,_,
          consistent_JJ with_IN what_WP might_MD be_VB expected_VBN from_IN the_DT loss_NN of_IN
          one_CD allele_NN ._. Whether_IN there_EX is_VBZ compensation_NN by_IN increased_VBN
          expression_NN of_IN other_JJ γ_NN subunits_NNS such_JJ as_IN the_DT γ_NN 
          6_CD and_CC γ_NN 
          7_CD subunits_NNS ,_, which_WDT were_VBD shown_VBN recently_RB
          to_TO be_VB present_JJ in_IN skeletal_NN muscle_NN by_IN RT-PCR_NNP [_NN 19_CD ]_NN ,_, or_CC
          alteration_NN of_IN the_DT amount_NN of_IN the_DT other_JJ subunits_NNS remains_VBZ to_TO
          be_VB determined_VBN in_IN the_DT future_NN ._.
        
        
          Increase_VB in_IN Ca_MD 2_CD +_NN current_JJ density_NN and_CC decrease_VB in_IN
          inactivation_NN in_IN γ_NN 1_CD null_NN and_CC γ_NN 1_CD het_NN myotubes_NNS
          We_PRP examined_VBD the_DT impact_NN of_IN the_DT γ_NN 
          1_CD null_NN mutation_NN on_IN DHPR_NNP properties_NNS
          using_VBG electrophysiological_JJ techniques_NNS in_IN primary_JJ cultures_NNS
          of_IN skeletal_NN myotubes_NNS derived_VBN from_IN mouse_NN embryos_NNS ._. Fig_NNP ._.
          2_LS Ashows_NNP whole-cell_JJ Ca_MD 2_CD +_NN currents_NNS in_IN control_NN ,_, γ_NN 
          1_CD het_NN and_CC γ_NN 
          1_CD null_NN myotubes_NNS in_IN response_NN to_TO 500_CD -_: ms_NNS
          depolarizing_VBG voltage_NN steps_NNS from_IN a_DT holding_VBG potential_NN of_IN
          -_: 40_CD mV_NN ._. Current_JJ traces_NNS for_IN only_RB three_CD voltage_NN steps_NNS are_VBP
          shown_VBN for_IN clarity_NN ._. All_DT three_CD cell_NN types_NNS displayed_VBD the_DT
          slow_JJ ,_, high-voltage_JJ activated_VBN L-_NNP type_NN Ca_MD 2_CD +_NN current_JJ typical_JJ
          of_IN skeletal_NN myotubes_NNS ._. When_WRB the_DT holding_VBG potential_NN was_VBD -_: 80_CD
          mV_NN ,_, we_PRP also_RB observed_VBD a_DT T-_NNP type_NN Ca_MD 2_CD +_NN current_NN ,_, which_WDT was_VBD
          seen_VBN in_IN approximately_RB half_NN of_IN the_DT cells_NNS tested_VBN (_( data_NNS not_RB
          shown_VBN )_) ._. Ca_MD 2_CD +_NN conductance_NN vs_NNS ._. voltage_NN curves_NNS were_VBD computed_JJ
          in_IN Fig_NNP ._. 2_LS Bfor_NNP the_DT three_CD cell_NN types_NNS ._. The_DT sigmoidal_NN lines_NNS
          correspond_VB to_TO a_DT Boltzmann_NNP fit_VBP to_TO the_DT population_NN mean_NN
          while_IN parameters_NNS fitted_JJ to_TO each_DT cell_NN are_VBP shown_VBN in_IN Table_NNP
          1_CD ._. These_DT data_NNS show_VBP that_IN the_DT maximum_NN conductance_NN ,_, G_NNP 
          max_NN ,_, for_IN both_DT the_DT γ_NN 
          1_CD het_NN and_CC γ_NN 
          1_CD null_NN cells_NNS are_VBP significantly_RB larger_JJR
          (_( p_NN <_NN 0_CD ._. 05_CD )_) than_IN the_DT values_NNS for_IN control_NN cells_NNS ._. However_RB ,_,
          the_DT half-activation_JJ potential_JJ (_( V_NNP 
          1_CD /_NN 2_LS )_) and_CC the_DT steepness_NN of_IN the_DT curve_NN
          (_( factor_NN k_NN )_) were_VBD not_RB significantly_RB different_JJ (_( see_VB Table_NNP
          1_LS )_) ._. Thus_RB ,_, full_JJ or_CC partial_JJ elimination_NN of_IN the_DT γ_NN 
          1_CD subunit_NN produced_VBD a_DT significant_JJ
          increase_NN in_IN the_DT Ca_MD 2_CD +_NN current_JJ density_NN without_IN a_DT change_NN in_IN
          the_DT voltage-dependence_JJ of_IN the_DT Ca_MD 2_CD +_NN conductance_NN ._.
          At_IN intermediate_JJ potentials_NNS such_JJ as_IN +_NN 30_CD mV_NN (_( Fig_NNP ._. 2_LS A_DT )_) ,_,
          the_DT Ca_MD 2_CD +_NN current_NN of_IN γ_NN 
          1_CD het_NN and_CC γ_NN 
          1_CD null_NN cells_NNS inactivated_JJ more_RBR slowly_RB
          than_IN that_DT of_IN control_NN cells_NNS ._. To_TO examine_VB changes_NNS in_IN
          inactivation_NN ,_, we_PRP used_VBD the_DT paired-pulse_JJ protocol_NN shown_VBN in_IN
          Fig_NNP ._. 3_LS A_DT ,_, which_WDT measured_VBD the_DT Ca_MD 2_CD +_NN current_JJ not_RB inactivated_JJ
          by_IN the_DT pre-pulse_JJ ._. It_PRP has_VBZ been_VBN shown_VBN that_DT inactivation_NN of_IN
          skeletal_NN L-_NNP type_NN Ca_MD 2_CD +_NN channels_NNS approaches_NNS steady-state_JJ
          extremely_RB slowly_RB ,_, on_IN the_DT time_NN scale_NN of_IN tens_NNS of_IN seconds_NNS [_NN
          21_CD ]_NN ._. However_RB ,_, for_IN comparative_JJ purposes_NNS and_CC to_TO be_VB
          consistent_JJ with_IN previous_JJ measurements_NNS in_IN Ca_MD 2_CD +_NN channels_NNS
          lacking_VBG γ_NN 
          1_CD [_NN 20_CD ,_, 22_CD ]_NN ,_, we_PRP chose_VBD a_DT much_RB shorter_JJR
          protocol_NN ._. Cells_NNP were_VBD held_VBN at_IN -_: 80_CD mV_NN ,_, then_RB stepped_VBD to_TO a_DT
          series_NN of_IN depolarizing_VBG (_( pre-pulse_JJ )_) voltages_NNS for_IN 2_CD ._. 5_CD s_VBZ to_TO
          promote_VB inactivation_NN ,_, then_RB stepped_VBD to_TO -_: 50_CD mV_NN for_IN 100_CD ms_NNS
          to_TO close_VB non-inactivated_JJ channels_NNS ._. The_DT non-inactivated_JJ Ca_MD
          2_CD +_NN current_NN was_VBD measured_VBN during_IN a_DT 200_CD -_: ms_NNS test_VBP pulse_NN to_TO +_NN 20_CD
          mV_NN ._. In_IN control_NN cells_NNS ,_, there_EX was_VBD almost_RB complete_JJ
          inactivation_NN of_IN the_DT Ca_MD 2_CD +_NN current_JJ when_WRB the_DT pre-pulse_JJ
          potential_NN was_VBD in_IN the_DT positive_JJ range_NN ._. This_DT can_MD be_VB seen_VBN by_IN
          comparing_VBG the_DT amplitude_NN of_IN the_DT Ca_MD 2_CD +_NN current_JJ during_IN the_DT
          test_NN pulse_NN in_IN traces_NNS 1_CD ,_, 2_CD ,_, and_CC 3_CD ,_, corresponding_JJ to_TO
          pre-pulse_JJ potentials_NNS to_TO -_: 70_CD mV_NN ,_, +_NN 30_CD mV_NN ,_, and_CC +_NN 60_CD mV_NN ,_,
          respectively_RB ._. In_IN contrast_NN ,_, γ_NN 
          1_CD het_NN and_CC γ_NN 
          1_CD null_NN cells_NNS showed_VBD less_JJR inactivation_NN
          during_IN the_DT pre-pulse_JJ ,_, and_CC thus_RB a_DT significantly_RB larger_JJR Ca_MD
          2_CD +_NN current_JJ during_IN the_DT test_NN pulse_NN ._. Furthermore_RB ,_, pre-pulse_JJ
          potentials_NNS larger_JJR than_IN +_NN 30_CD mV_NN did_VBD not_RB promote_VB additional_JJ
          inactivation_NN ,_, which_WDT can_MD be_VB seen_VBN by_IN comparing_VBG traces_NNS 2_CD and_CC
          3_CD in_IN the_DT γ_NN 
          1_CD het_NN and_CC γ_NN 
          1_CD null_NN cells_NNS ._. Fig_NNP ._. 3_LS Bshows_NNP the_DT maximum_NN
          Ca_MD 2_CD +_NN current_JJ during_IN the_DT test_NN pulse_NN plotted_VBD as_IN a_DT function_NN
          of_IN the_DT pre-pulse_JJ potential_NN ._. In_IN control_NN cells_NNS ,_,
          inactivation_NN was_VBD complete_JJ when_WRB the_DT pre-pulse_JJ potential_NN
          was_VBD above_IN +_NN 30_CD mV_NN (_( -_: 6_CD ._. 9_CD ±_NN 0_CD ._. 8_CD pA_NN /_NN pF_NN at_IN -_: 70_CD mV_NN vs_NNS ._. -_: 0_CD ._. 2_LS ±_NN
          0_CD ._. 2_CD pA_NN /_NN pF_NN at_IN +_NN 70_CD mV_NN ,_, n_NN =_SYM 6_CD cells_NNS )_) ._. In_IN γ_NN 
          1_CD null_NN cells_NNS ,_, inactivation_NN reached_VBD a_DT
          plateau_NN when_WRB the_DT pre-pulse_JJ potential_NN was_VBD more_RBR positive_JJ
          than_IN +_NN 20_CD mV_NN (_( -_: 8_CD ._. 5_LS ±_NN 0_CD ._. 9_CD pA_NN /_NN pF_NN at_IN -_: 70_CD mV_NN vs_NNS ._. -_: 3_CD ._. 2_LS ±_NN 0_CD ._. 7_CD
          pA_NN /_NN pF_NN at_IN +_NN 70_CD mV_NN ,_, n_NN =_SYM 8_CD cells_NNS )_) ._. Incomplete_NNP inactivation_NN
          was_VBD also_RB seen_VBN in_IN γ_NN 
          1_CD het_NN cells_NNS ,_, although_IN this_DT was_VBD less_RBR
          pronounced_JJ than_IN in_IN γ_NN 
          1_CD null_NN cells_NNS ._. Since_IN the_DT pre-pulse_JJ was_VBD
          not_RB sufficiently_RB long_RB for_IN inactivation_NN to_TO reach_VB
          steady-state_JJ ,_, we_PRP are_VBP not_RB certain_JJ whether_IN the_DT observed_VBN
          incomplete_JJ inactivation_NN reflects_VBZ a_DT component_NN of_IN the_DT γ_NN 
          1_CD null_NN Ca_MD 2_CD +_NN current_JJ that_IN inactivates_NNS
          extremely_RB slowly_RB or_CC a_DT "_'' truly_RB "_'' non-inactivating_JJ component_NN ._.
          To_TO compare_VB the_DT voltage-dependence_JJ of_IN the_DT inactivation_NN
          produced_VBN by_IN the_DT 2_CD ._. 5_CD -_: second_JJ pre-pulse_JJ ,_, the_DT Ca_MD 2_CD +_NN current_JJ
          during_IN the_DT test_NN pulse_NN was_VBD normalized_JJ and_CC fit_VB to_TO the_DT
          Boltzmann_NNP equation_NN (_( Fig_NNP ._. 3_LS C_NNP )_) ._. The_DT curves_NNS for_IN γ_NN 
          1_CD het_NN and_CC γ_NN 
          1_CD null_NN cells_NNS showed_VBD a_DT significant_JJ
          (_( p_NN <_NN 0_CD ._. 05_CD )_) shift_NN to_TO more_RBR positive_JJ potentials_NNS compared_VBN to_TO
          control_VB cells_NNS ._. The_DT same_JJ conclusion_NN was_VBD reached_VBN by_IN
          comparing_VBG the_DT Boltzmann_NNP parameters_NNS of_IN individual_JJ cells_NNS in_IN
          Table_NNP 1_CD ._. Since_IN control_NN cells_NNS had_VBD a_DT more_RBR negative_JJ half_JJ
          inactivation_NN potential_JJ ,_, the_DT higher_JJR Ca_MD 2_CD +_NN conductance_NN of_IN γ_NN 
          1_CD het_NN and_CC γ_NN 
          1_CD null_NN cells_NNS reported_VBD in_IN Fig_NNP ._. 2_LS could_MD
          be_VB explained_VBN by_IN a_DT larger_JJR steady-state_JJ inactivation_NN of_IN the_DT
          control_NN Ca_MD 2_CD +_NN current_JJ at_IN the_DT -_: 40_CD mV_NN holding_VBG potential_JJ ._. To_TO
          determine_VB if_IN this_DT was_VBD the_DT case_NN ,_, we_PRP measured_VBD the_DT Ca_MD
          2_CD +_NN conductance_NN during_IN the_DT pre-pulse_JJ for_IN the_DT same_JJ cells_NNS
          analyzed_VBD in_IN Fig_NNP 3_CD B_NNP ,_, C_NNP ._. The_DT pre-pulse_JJ was_VBD delivered_VBN from_IN a_DT
          holding_VBG potential_NN of_IN -_: 80_CD mV_NN ,_, and_CC therefore_RB the_DT pre-pulse_JJ
          current_NN should_MD be_VB less_RBR contaminated_VBN by_IN steady-state_JJ
          inactivation_NN ._. G_NNP 
          max_NN at_IN the_DT peak_NN of_IN the_DT Ca_MD 2_CD +_NN current_JJ
          during_IN the_DT pre-pulse_JJ was_VBD 146_CD ±_NN 12_CD pS_NN /_NN pF_NN for_IN controls_NNS ,_, 172_CD
          ±_NN 18_CD pS_NN /_NN pF_NN γ_NN 
          1_CD het_NN and_CC 186_CD ±_NN 13_CD pS_NN /_NN pF_NN for_IN γ_NN 
          1_CD null_NN cells_NNS with_IN t-test_JJ statistical_JJ
          significance_NN for_IN controls_NNS vs_NNS ._. γ_NN 
          1_CD null_NN cells_NNS of_IN p_NN =_SYM 0_CD ._. 034_CD and_CC for_IN
          controls_NNS vs_NNS ._. γ_NN 
          1_CD het_NN cells_NNS of_IN p_NN =_SYM 0_CD ._. 064_CD ._. Thus_RB the_DT
          higher_JJR Ca_MD 2_CD +_NN conductance_NN of_IN γ_NN 
          1_CD het_NN and_CC γ_NN 
          1_CD null_NN cells_NNS persisted_VBD at_IN the_DT more_RBR
          negative_JJ holding_NN potential_JJ ._. These_DT Ca_MD 2_CD +_NN conductances_NNS were_VBD
          approximately_RB 10_CD %_NN higher_JJR than_IN those_DT at_IN the_DT -_: 40_CD mV_NN holding_VBG
          potential_NN reported_VBD in_IN Table_NNP 1_CD ._. The_DT additional_JJ current_JJ
          could_MD have_VB been_VBN contributed_VBN by_IN T-_NNP type_NN Ca_MD 2_CD +_NN channels_NNS (_( not_RB
          shown_VBN )_) ,_, which_WDT are_VBP available_JJ at_IN the_DT -_: 80_CD mV_NN holding_VBG
          potential_JJ but_CC are_VBP inactivated_JJ at_IN the_DT more_RBR positive_JJ
          holding_NN potential_JJ ._. Also_RB ,_, since_IN the_DT T-_NNP type_NN Ca_MD 2_CD +_NN current_JJ
          density_NN was_VBD highly_RB variable_JJ (_( see_VB above_IN )_) ,_, this_DT could_MD
          explain_VB the_DT higher_JJR p_NN values_NNS compared_VBN to_TO those_DT reported_VBD in_IN
          Table_NNP 1_CD ._. In_IN summary_NN ,_, decreasing_VBG the_DT amount_NN of_IN the_DT γ_NN 
          1_CD subunit_NN protein_NN or_CC eliminating_VBG it_PRP
          completely_RB resulted_VBD in_IN myotubes_NNS with_IN a_DT higher_JJR Ca_MD
          2_CD +_NN current_JJ density_NN ,_, a_DT similar_JJ voltage-dependence_JJ of_IN
          activation_NN ,_, and_CC a_DT reduced_VBN rate_NN of_IN inactivation_NN ._. These_DT
          results_NNS ,_, with_IN the_DT exception_NN of_IN the_DT change_NN in_IN Ca_MD 2_CD +_NN current_JJ
          density_NN ,_, are_VBP in_IN remarkable_JJ agreement_NN with_IN those_DT obtained_VBN
          when_WRB L-_NNP type_NN Ca_MD 2_CD +_NN channel_NN subunits_NNS are_VBP coexpressed_JJ without_IN
          the_DT γ_NN 
          1_CD subunit_NN in_IN heterologous_JJ cells_NNS (_( see_VB
          below_IN )_) ._. They_PRP also_RB are_VBP similar_JJ to_TO results_NNS obtained_VBN
          elsewhere_RB in_IN γ_NN 
          1_CD null_NN myotubes_NNS using_VBG a_DT 5_CD -_: second_JJ
          pre-pulse_JJ [_NN 20_CD ]_NN ._. Furthermore_RB ,_, the_DT incomplete_JJ inactivation_NN
          of_IN the_DT γ_NN 
          1_CD null_NN Ca_MD 2_CD +_NN current_JJ resembles_VBZ that_WDT
          observed_VBN in_IN ts_NNS A_DT 201_CD cells_NNS expressing_VBG DHPRs_NNP specifically_RB
          lacking_VBG γ_NN 
          1_CD and_CC using_VBG a_DT 3_CD -_: second_JJ inactivation_NN
          protocol_NN [_NN 22_CD ]_NN ._.
          The_DT effect_NN of_IN the_DT γ_NN 
          1_CD subunit_NN on_IN Ca_MD 2_CD +_NN current_JJ kinetics_NNS has_VBZ
          been_VBN somewhat_RB confusing_JJ until_IN now_RB ,_, because_IN it_PRP has_VBZ not_RB
          been_VBN possible_JJ to_TO examine_VB its_PRP$ role_NN using_VBG homologous_RB
          subunits_NNS and_CC a_DT homologous_RB expression_NN system_NN ._. In_IN amphibian_NN
          oocytes_NNS ,_, γ_NN 
          1_CD was_VBD assayed_JJ in_IN a_DT complex_NN with_IN α_NN 
          1_CD C_NNP ,_, β_NN 
          1_CD a_DT and_NN α_NN 
          2_CD -_: δ_NN [_NN 23_CD ,_, 24_CD ]_NN ._. These_DT investigators_NNS
          found_VBD γ_NN 
          1_CD produced_VBD a_DT slight_JJ decrease_NN in_IN Ca_MD
          2_CD +_NN current_JJ density_NN ,_, no_DT change_NN in_IN activation_NN kinetics_NNS and_CC a_DT
          positive_JJ shift_NN in_IN the_DT peak_NN Ca_MD 2_CD +_NN current_JJ vs_NNS ._. voltage_NN
          curve_NN ._. In_IN HEK_NNP 293_CD cells_NNS using_VBG the_DT same_JJ subunit_NN
          composition_NN ,_, the_DT γ_NN 
          1_CD subunit_NN did_VBD not_RB alter_VB the_DT kinetics_NNS
          or_CC density_NN of_IN Ca_MD 2_CD +_NN currents_NNS [_NN 25_CD ]_NN ._. However_RB ,_, in_IN both_DT
          oocytes_NNS and_CC HEK_NNP 293_CD cells_NNS ,_, the_DT γ_NN 
          1_CD subunit_NN increased_VBD the_DT rate_NN of_IN Ca_MD
          2_CD +_NN channel_NN inactivation_NN and_CC produced_VBD a_DT large_JJ
          hyperpolarizing_VBG shift_NN in_IN steady-state_JJ inactivation_NN [_NN 23_CD ,_,
          25_CD ,_, 26_CD ]_NN ._. The_DT results_NNS obtained_VBN here_RB in_IN skeletal_NN muscle_NN
          demonstrate_VB that_DT absence_NN of_IN the_DT γ_NN 
          1_CD subunit_NN increases_NNS Ca_MD 2_CD +_NN current_JJ
          density_NN ,_, decreases_VBZ the_DT inactivation_NN rate_NN ,_, and_CC shifts_VBZ the_DT
          voltage-dependence_JJ of_IN inactivation_NN in_IN the_DT depolarizing_VBG
          direction_NN ._. Freise_NNP et_CC al_NN ._. [_NN 20_CD ]_NN showed_VBD that_IN the_DT increase_NN
          in_IN Ca_MD 2_CD +_NN current_NN was_VBD not_RB a_DT result_NN of_IN changes_NNS in_IN single_JJ
          channel_NN conductance_NN and_CC suggested_VBD the_DT effects_NNS were_VBD due_JJ to_TO
          changes_NNS in_IN channel_NN open_JJ probability_NN ._. However_RB ,_, this_DT
          remains_VBZ to_TO be_VB tested_VBN directly_RB ._. Expression_NNP of_IN the_DT γ_NN 
          2_CD subunit_NN in_IN BHK_NNP cells_NNS expressing_VBG α_NN 
          1_CD A_DT ,_, α_NN 
          2_CD -_: δ_NN and_CC β_NN 
          1_CD a_DT also_RB shifts_VBZ the_DT voltage-dependence_JJ
          of_IN inactivation_NN ∼_NN 7_CD mV_NN in_IN the_DT hyperpolarizing_VBG direction_NN [_NN
          17_CD ]_NN ._. In_IN summary_NN ,_, the_DT two_CD γ_NN subunits_NNS that_WDT have_VBP been_VBN
          characterized_VBN to_TO date_NN ,_, namely_RB γ_NN 
          1_CD in_IN the_DT homologous_RB skeletal_NN myotube_NN
          system_NN described_VBD here_RB and_CC γ_NN 
          2_CD described_VBD above_IN in_IN heterologous_JJ BHK_NNP
          cells_NNS [_NN 17_CD ]_NN ,_, appear_VB to_TO be_VB inhibitory_NN ._. In_IN each_DT case_NN ,_, the_DT
          presence_NN of_IN γ_NN results_NNS in_IN fewer_JJR Ca_MD 2_CD +_NN channels_NNS available_JJ
          for_IN activation_NN ._.
        
        
          Absence_NNP of_IN changes_NNS in_IN the_DT EC_NNP coupling_NN voltage_NN
          sensor_NN of_IN γ_NN 1_CD nullmyotubes_NNS
          The_DT impact_NN of_IN the_DT γ_NN 
          1_CD null_NN mutation_NN on_IN myotube_NN EC_NNP coupling_NN
          was_VBD inferred_VBN from_IN intramembrane_NN charge_NN movements_NNS ,_, the_DT
          bulk_NN of_IN which_WDT have_VBP been_VBN shown_VBN to_TO originate_VB from_IN the_DT DHPR_NNP
          voltage_NN sensor_NN [_NN 27_CD ,_, 28_CD ]_NN ._. Additionally_RB ,_, we_PRP measured_VBD Ca_MD
          2_CD +_NN transients_NNS evoked_JJ by_IN voltage_NN (_( i_NNP ._. e_SYM ._. ,_, by_IN the_DT movement_NN of_IN
          the_DT voltage_NN sensor_NN )_) and_CC compared_VBD these_DT two_CD sets_NNS of_IN data_NNS ._.
          To_TO measure_VB DHPR_NNP charge_NN movements_NNS and_CC to_TO separate_VB these_DT
          charge_NN movements_NNS from_IN those_DT produced_VBN by_IN other_JJ
          voltage-gated_JJ channels_NNS ,_, a_DT )_) ionic_JJ currents_NNS were_VBD blocked_VBN ;_:
          b_SYM )_) the_DT linear_JJ component_NN of_IN the_DT cell_NN capacity_NN was_VBD
          subtracted_VBN using_VBG a_DT P_NN /_NN 4_CD procedure_NN and_CC by_IN analog_NN
          compensation_NN ;_: and_CC c_SYM )_) we_PRP used_VBD a_DT pulse_NN protocol_NN that_WDT
          eliminated_VBD the_DT immobilization-sensitive_JJ charge_NN movements_NNS
          from_IN voltage-gated_JJ Na_NNP +_NN channels_NNS and_CC presumably_RB also_RB from_IN
          T-_NNP type_NN Ca_MD 2_CD +_NN channels_NNS ._. Previous_JJ studies_NNS in_IN dysgenic_JJ (_( α_NN 
          1_CD S_NNP null_NN )_) myotubes_NNS transfected_JJ with_IN α_NN 
          1_CD S_NNP showed_VBD that_IN the_DT pulse_NN protocol_NN and_CC
          the_DT internal_JJ and_CC external_JJ solutions_NNS used_VBN here_RB (_( see_VB
          Materials_NNPS and_CC Methods_NNP )_) detected_VBD charge_NN movements_NNS of_IN a_DT
          magnitude_NN 5_CD to_TO 8_CD fold_VB larger_JJR than_IN those_DT present_NN in_IN
          non-transfected_JJ dysgenic_JJ myotubes_NNS [_NN 28_CD ]_NN ._. Thus_RB we_PRP are_VBP
          confident_JJ that_IN the_DT technique_NN adequately_RB measures_VBZ
          intramembrane_NN charge_NN movements_NNS in_IN DHPR_NNP voltage_NN sensors_NNS
          present_JJ in_IN the_DT plasma_NN membrane_NN ._. Fig_NNP ._. 4_LS Ashows_NNP
          "_'' gating-type_JJ "_'' currents_NNS produced_VBN by_IN charge_NN movements_NNS in_IN
          response_NN to_TO 3_CD of_IN 14_CD step_NN voltages_NNS delivered_VBN to_TO each_DT cell_NN
          (_( -_: 40_CD ,_, +_NN 10_CD ,_, and_CC +_NN 70_CD mV_NN )_) ._. Charge_VB movements_NNS did_VBD not_RB occur_VB at_IN
          -_: 40_CD mV_NN in_IN any_DT of_IN the_DT cell_NN types_NNS ._. Traces_NNP at_IN +_NN 10_CD mV_NN and_CC +_NN 70_CD
          mV_NN show_NN a_DT transient_JJ current_NN at_IN the_DT onset_NN of_IN the_DT voltage_NN
          step_NN ,_, the_DT ON_NNP charge_NN ,_, and_CC an_DT equal_JJ inverted_JJ current_NN at_IN the_DT
          end_NN of_IN the_DT voltage_NN step_NN ,_, the_DT OFF_NNP charge_NN ._. The_DT
          voltage-dependence_JJ of_IN the_DT OFF_NNP charge_NN estimated_VBN by_IN
          integration_NN is_VBZ shown_VBN in_IN Fig_NNP ._. 4_LS B_NNP ._. The_DT OFF_NNP transient_JJ was_VBD
          usually_RB less_RBR contaminated_VBN by_IN ionic_JJ current_NN than_IN the_DT ON_NNP
          transient_JJ ,_, and_CC for_IN that_DT reason_NN it_PRP provides_VBZ a_DT better_JJR
          estimate_NN of_IN the_DT total_JJ DHPR_NNP charge_NN ._. The_DT main_JJ contaminant_NN
          of_IN the_DT ON_NNP transient_JJ was_VBD a_DT non-linear_JJ outward_RB current_JJ ,_,
          presumably_RB a_DT K_NNP +_NN channel_NN that_WDT was_VBD not_RB always_RB completely_RB
          blocked_VBN by_IN the_DT pipette_NN solution_NN ._. The_DT OFF_NNP charge_NN increased_VBD
          in_IN a_DT sigmoidal_NN fashion_NN and_CC saturated_VBD at_IN potentials_NNS more_RBR
          positive_JJ than_IN +_NN 60_CD mV_NN in_IN all_DT cases_NNS ._. These_DT data_NNS were_VBD
          adequately_RB fit_VBN by_IN a_DT Boltzmann_NNP equation_NN shown_VBN by_IN the_DT
          lines_NNS ._. We_PRP found_VBD that_IN the_DT fitted_JJ maximum_NN charge_NN (_( Q_NNP 
          max_NN )_) expressed_VBN by_IN the_DT 3_CD cell_NN types_NNS
          was_VBD ∼_NN 5_CD fC_NN /_NN pF_NN ,_, in_IN agreement_NN with_IN previous_JJ determinations_NNS
          in_IN normal_JJ myotubes_NNS [_NN 29_CD ]_NN ._. Furthermore_RB ,_, Boltzmann_NNP
          parameters_NNS determined_VBN for_IN each_DT cell_NN and_CC then_RB averaged_VBD
          were_VBD not_RB significantly_RB different_JJ in_IN any_DT of_IN two-by-two_JJ
          comparisons_NNS between_IN control_NN ,_, γ_NN 
          1_CD het_NN or_CC γ_NN 
          1_CD null_NN cells_NNS (_( Table_NNP 1_LS )_) ._. In_IN summary_NN ,_,
          the_DT magnitude_NN of_IN intramembrane_NN charge_NN movements_NNS and_CC its_PRP$
          voltage_NN dependence_NN were_VBD unaltered_JJ by_IN partial_JJ or_CC complete_JJ
          removal_NN of_IN the_DT γ_NN 
          1_CD subunit_NN ._. Furthermore_RB ,_, in_IN agreement_NN
          with_IN previous_JJ data_NNS [_NN 29_CD ]_NN ,_, no_DT additional_JJ charges_NNS moved_VBD
          when_WRB pulses_NNS were_VBD delivered_VBN from_IN a_DT holding_VBG potential_NN of_IN
          -_: 120_CD mV_NN (_( data_NNS not_RB shown_VBN )_) ._. Thus_RB ,_, failure_NN to_TO detect_VB changes_NNS
          in_IN the_DT charge_NN vs_NNS ._. voltage_NN characteristics_NNS of_IN γ_NN 
          1_CD null_NN myotubes_NNS compared_VBN to_TO controls_NNS
          cannot_NN be_VB explained_VBN by_IN charge_NN movements_NNS in_IN the_DT γ_NN 
          1_CD null_NN myotubes_NNS occurring_VBG at_IN
          potentials_NNS more_RBR negative_JJ than_IN the_DT chosen_VBN -_: 80_CD mV_NN holding_VBG
          potential_JJ ._.
          Absence_NNP of_IN alterations_NNS in_IN the_DT voltage_NN dependence_NN of_IN
          charge_NN movement_NN in_IN the_DT γ_NN 
          1_CD null_NN cells_NNS should_MD also_RB be_VB reflected_VBN
          in_IN the_DT voltage-dependence_JJ of_IN Ca_MD 2_CD +_NN transients_NNS ._. Changes_NNS in_IN
          intracellular_NN Ca_MD 2_CD +_NN were_VBD measured_VBN using_VBG confocal_NN line-scan_JJ
          imaging_NN of_IN fluo-_NN 4_CD fluorescence_NN ._. Fig_NNP ._. 5_LS Ashows_NNP a_DT line-scan_JJ
          image_NN of_IN a_DT Ca_MD 2_CD +_NN transient_JJ stimulated_VBN by_IN a_DT 50_CD ms_NNS
          depolarization_NN to_TO +_NN 90_CD mV_NN from_IN a_DT holding_VBG potential_NN of_IN -_: 40_CD
          mV_NN in_IN each_DT cell_NN type_NN ._. The_DT scan_VB direction_NN was_VBD
          perpendicular_NN to_TO the_DT long_JJ axis_NNS of_IN the_DT myotube_NN in_IN a_DT region_NN
          selected_VBN on_IN the_DT basis_NN of_IN a_DT low_JJ resting_VBG fluorescence_NN and_CC a_DT
          high_RB stimulated_VBN fluorescence_NN (_( red_JJ /_NN yellow_JJ color_NN )_) ._. The_DT two_CD
          traces_NNS on_IN top_NN of_IN each_DT image_NN correspond_VB to_TO the_DT time_NN course_NN
          of_IN the_DT fluo-_NN 4_CD fluorescence_NN averaged_VBD across_IN the_DT entire_JJ
          line-scan_JJ at_IN -_: 10_CD mV_NN ,_, which_WDT is_VBZ close_JJ to_TO the_DT threshold_NN ,_, and_CC
          at_IN +_NN 90_CD mV_NN ,_, which_WDT produced_VBD the_DT maximum_NN Ca_MD 2_CD +_NN transient_JJ ._.
          Increase_VB in_IN cytosolic_JJ Ca_MD 2_CD +_NN started_VBD at_IN the_DT onset_NN of_IN the_DT
          depolarization_NN and_CC peaked_VBD ∼_NN 100_CD ms_NNS later_RB in_IN the_DT three_CD
          cell_NN types_NNS ._. For_IN all_DT cells_NNS ,_, the_DT peak_NN fluorescence_NN change_NN
          for_IN the_DT depolarization_NN to_TO +_NN 90_CD mV_NN was_VBD >_NN 3_CD ΔF_NN /_NN Fo_NNP units_NNS ,_,
          which_WDT is_VBZ equivalent_JJ to_TO >_NN 4_CD times_NNS the_DT resting_VBG
          fluorescence_NN ._. The_DT relatively_RB long_JJ recovery_NN time_NN following_VBG
          the_DT depolarization_NN is_VBZ due_JJ to_TO the_DT low_JJ Ca_MD 2_CD +_NN buffering_VBG power_NN
          of_IN the_DT internal_JJ recording_NN solution_NN and_CC is_VBZ in_IN agreement_NN
          with_IN previous_JJ studies_NNS [_NN 27_CD ,_, 30_CD ]_NN ._. The_DT voltage_NN dependence_NN
          of_IN ΔF_NN /_NN Fo_NNP measured_VBD at_IN the_DT peak_NN of_IN the_DT transient_JJ is_VBZ shown_VBN
          in_IN Fig_NNP ._. 5_LS B_NNP ._. All_DT curves_NNS had_VBD the_DT same_JJ profile_NN which_WDT
          consisted_VBD of_IN a_DT threshold_NN for_IN peak_NN Ca_MD 2_CD +_NN release_NN at_IN -_: 10_CD mV_NN ,_,
          an_DT increase_NN in_IN peak_NN Ca_MD 2_CD +_NN with_IN pulse_NN potential_JJ from_IN -_: 10_CD mV_NN
          to_TO +_NN 30_CD mV_NN and_CC a_DT plateau_NN at_IN more_JJR positive_JJ potentials_NNS ._.
          Furthermore_RB ,_, two-by-two_JJ comparisons_NNS of_IN Boltzmann_NNP
          parameters_NNS fitted_JJ to_TO each_DT cell_NN did_VBD not_RB reveal_VB
          statistically_RB significant_JJ differences_NNS (_( see_VB Table_NNP 1_LS )_) ._. In_IN
          summary_NN ,_, the_DT voltage-dependence_JJ of_IN Ca_MD 2_CD +_NN transients_NNS and_CC
          the_DT maximum_NN cytosolic_JJ Ca_MD 2_CD +_NN concentration_NN during_IN the_DT
          transient_JJ were_VBD not_RB significantly_RB affected_VBN by_IN partial_JJ or_CC
          total_JJ absence_NN of_IN the_DT γ_NN 
          1_CD subunit_NN ._. However_RB ,_, we_PRP cannot_NN rule_NN out_RP
          changes_NNS in_IN the_DT rate_NN of_IN SR_NNP Ca_NNP 2_CD +_NN release_NN since_IN this_DT
          measurement_NN requires_VBZ an_DT entirely_RB different_JJ internal_JJ
          solution_NN [_NN 31_CD ]_NN ._. A_DT recent_JJ report_NN indicates_VBZ that_IN the_DT SR_NNP Ca_NNP
          2_CD +_NN release_NN rate_NN is_VBZ slightly_RB higher_JJR in_IN γ_NN 
          1_CD null_NN myotubes_NNS [_NN 32_CD ]_NN ._.
        
        
          Involvement_NNP of_IN DHPR_NNP subunits_NNS in_IN voltage_NN sensing_VBG and_CC
          EC_NNP coupling_NN
          The_DT α_NN 
          1_CD S_NNP pore_NN subunit_NN of_IN the_DT skeletal_NN DHPR_NNP
          is_VBZ the_DT main_JJ determinant_NN of_IN charge_NN movements_NNS and_CC EC_NNP
          coupling_NN [_NN 4_CD ,_, 27_CD ,_, 28_CD ]_NN ._. However_RB ,_, other_JJ subunits_NNS of_IN the_DT
          DHPR_NNP are_VBP critical_JJ modulators_NNS of_IN both_DT functions_NNS ._. In_IN
          heterologous_JJ expression_NN systems_NNS ,_, the_DT α_NN 
          2_CD -_: δ_NN subunit_NN was_VBD shown_VBN to_TO affect_VB the_DT
          rate_NN of_IN Ca_MD 2_CD +_NN current_JJ inactivation_NN and_CC charge_NN movement_NN
          immobilization_NN [_NN 33_CD ]_NN ._. Studies_NNS investigating_VBG the_DT role_NN of_IN
          the_DT β_NN subunit_NN on_IN charge_NN movement_NN vary_VBP with_IN the_DT expression_NN
          system_NN used_VBN ._. In_IN amphibian_NN oocytes_NNS ,_, β_NN subunits_NNS increase_VBP
          the_DT coupling_NN between_IN charge_NN movements_NNS and_CC channel_NN opening_VBG
          [_NN 34_CD ,_, 35_CD ]_NN ._. We_PRP have_VBP shown_VBN in_IN skeletal_NN muscle_NN cells_NNS lacking_VBG
          the_DT β_NN 
          1_CD subunit_NN that_DT reintroduction_NN of_IN
          variants_NNS of_IN β_NN 
          1_CD has_VBZ little_JJ effect_NN on_IN either_DT charge_NN
          movement_NN or_CC the_DT kinetics_NNS of_IN activation_NN of_IN the_DT expressed_VBN
          Ca_MD 2_CD +_NN current_JJ [_NN 15_CD ]_NN ._. However_RB ,_, the_DT carboxyl_NN terminus_JJ of_IN β_NN 1_CD a_DT
          is_VBZ an_DT important_JJ determinant_NN of_IN the_DT efficiency_NN of_IN the_DT
          coupling_NN between_IN charge_NN movement_NN and_CC Ca_MD 2_CD +_NN release_NN [_NN 15_CD ]_NN ._.
          In_IN contrast_NN to_TO these_DT results_NNS ,_, earlier_JJR studies_NNS in_IN which_WDT
          similar_JJ β_NN subunits_NNS were_VBD co-expressed_JJ with_IN α_NN 
          1_CD subunits_NNS in_IN oocytes_NNS indicated_VBD β_NN
          subunits_NNS had_VBD major_JJ effects_NNS on_IN Ca_MD 2_CD +_NN current_JJ density_NN and_CC
          gating_VBG kinetics_NNS [_NN 36_CD ,_, 37_CD ]_NN ._. While_IN the_DT reason_NN for_IN these_DT
          discrepancies_NNS is_VBZ unknown_JJ ,_, they_PRP highlight_VB the_DT fact_NN that_IN in_IN
          skeletal_NN muscle_NN ,_, the_DT gating_VBG characteristics_NNS of_IN the_DT L-_NNP type_NN
          Ca_MD 2_CD +_NN channel_NN might_MD be_VB controlled_VBN by_IN interactions_NNS beyond_IN
          those_DT taking_VBG place_NN among_IN subunits_NNS of_IN the_DT DHPR_NNP ._. For_IN
          example_NN ,_, a_DT region_NN of_IN RyR_NNP 1_CD has_VBZ been_VBN shown_VBN to_TO be_VB essential_JJ
          for_IN L-_NNP type_NN Ca_MD 2_CD +_NN current_JJ expression_NN [_NN 38_CD ]_NN ._. Such_JJ
          interaction_NN is_VBZ critical_JJ for_IN skeletal_NN DHPR_NNP function_NN and_CC is_VBZ
          unlikely_JJ to_TO occur_VB in_IN heterologous_JJ expression_NN systems_NNS ._.
        
      
      
        Conclusions_NNP
        The_DT ability_NN of_IN the_DT γ_NN 
        1_CD subunit_NN to_TO selectively_RB modulate_VBP the_DT
        pore_NN function_NN of_IN the_DT DHPR_NNP without_IN modulation_NN of_IN charge_NN
        movements_NNS or_CC the_DT voltage_NN dependence_NN of_IN Ca_MD 2_CD +_NN transients_NNS is_VBZ
        unique_JJ ,_, especially_RB since_IN other_JJ DHPR_NNP subunits_NNS participate_VBP in_IN
        both_DT functions_NNS ._. In_IN all_DT likelihood_NN ,_, the_DT charge_NN movement_NN
        protocol_NN failed_VBD to_TO detect_VB gating_VBG currents_NNS responsible_JJ for_IN
        opening_VBG the_DT Ca_MD 2_CD +_NN channel_NN ,_, which_WDT are_VBP quite_RB small_JJ and_CC are_VBP
        only_RB resolved_VBN for_IN depolarizations_NNS >_NN 200_CD ms_NNS [_NN 39_CD ]_NN compared_VBN
        to_TO the_DT 25_CD ms_NNS used_VBN here_RB (_( Fig_NNP ._. 4_LS )_) ._. A_DT possible_JJ shift_NN in_IN the_DT
        voltage-dependence_JJ of_IN these_DT charges_NNS recruited_VBN by_IN long_JJ
        depolarizations_NNS would_MD be_VB consistent_JJ with_IN the_DT shift_NN in_IN Ca_MD
        2_CD +_NN current_JJ inactivation_NN and_CC remains_VBZ to_TO be_VB resolved_VBN in_IN γ_NN 
        1_CD null_NN myotubes_NNS ._. However_RB ,_, the_DT protocol_NN
        accurately_RB measures_VBZ the_DT immobilization-resistant_JJ charge_NN
        movements_NNS that_WDT are_VBP known_VBN to_TO be_VB required_VBN for_IN skeletal-type_JJ
        EC_NNP coupling_NN [_NN 31_CD ,_, 40_CD ]_NN ._. Therefore_RB ,_, the_DT γ_NN 
        1_CD subunit_NN is_VBZ unlikely_JJ to_TO play_VB a_DT critical_JJ
        role_NN in_IN the_DT activation_NN of_IN SR_NNP Ca_NNP 2_CD +_NN release_NN ,_, in_IN agreement_NN
        with_IN a_DT recent_JJ report_NN [_NN 32_CD ]_NN ._. However_RB ,_, shifts_NNS in_IN voltage_NN
        dependence_NN below_IN the_DT limit_NN of_IN resolution_NN (_( see_VB Materials_NNPS and_CC
        Methods_NNP )_) and_CC effects_NNS on_IN charge_NN movement_NN and_CC Ca_MD 2_CD +_NN release_NN
        inactivation_NN cannot_NN be_VB completely_RB ruled_VBN out_RP ._. The_DT γ_NN 
        1_CD knockout_NN mice_NNS provide_VBP a_DT unique_JJ
        resource_NN to_TO understand_VB the_DT function_NN of_IN this_DT protein_NN in_IN
        myotubes_NNS in_IN molecular_JJ detail_NN ._.
      
      
        Materials_NNS and_CC Methods_NNP
        
          Gene_NNP targeting_VBG
          Bacteriophage_NNP clones_NNS containing_VBG portions_NNS of_IN the_DT γ_NN 
          1_CD gene_NN were_VBD isolated_VBN from_IN a_DT mouse_NN
          129_CD Sv_NNP genomic_JJ library_NN (_( Stratagene_NNP ,_, La_NNP Jolla_NNP ,_, CA_NNP #_# 946305_CD )_) ._.
          To_TO inactivate_NN the_DT γ_NN 
          1_CD gene_NN ,_, a_DT 4_CD ._. 4_CD kb_NN 
          Bam_UH HI_NNP /_NN 
          Xho_NNP I_PRP fragment_NN upstream_RB of_IN exon_NN 1_CD
          was_VBD subcloned_JJ into_IN a_DT multiple_JJ cloning_VBG site_NN 5_CD '_POS of_IN the_DT 
          neo_NN and_CC Herpes_NNP virus_NN TK_NNP gene_NN that_WDT
          was_VBD in_IN pBluescript_NN (_( Stratagene_NNP )_) ._. A_DT second_JJ 2_CD ._. 6_CD kb_NN 
          EcoR_NNP I_PRP /_NN 
          BamH_NNP I_PRP fragment_NN 3_CD '_POS of_IN exon_NN 4_CD of_IN the_DT
          γ_NN 
          1_CD gene_NN was_VBD cloned_VBN into_IN a_DT site_NN between_IN
          the_DT 
          neo_NN and_CC TK_NNP genes_NNS (_( Fig_NNP ._. 1_LS Aii_NNP )_) ._. Thus_RB ,_,
          the_DT targeting_VBG vector_NN contains_VBZ 4_CD ._. 4_CD kb_NN of_IN identity_NN with_IN the_DT
          native_JJ γ_NN 
          1_CD gene_NN 5_CD '_POS ,_, and_CC 2_CD ._. 6_CD kb_NN of_IN identity_NN 3_CD '_POS
          of_IN the_DT 
          neo_NN cassette_NN ,_, respectively_RB ._. The_DT
          targeting_VBG vector_NN also_RB contains_VBZ the_DT HSV_NNP TK_NNP gene_NN to_TO allow_VB
          for_IN negative_JJ selection_NN of_IN non-recombinants_JJ ._. A_DT unique_JJ 
          Bam_UH HI_NNP restriction_NN site_NN was_VBD used_VBN to_TO
          linearize_NN the_DT plasmid_NN prior_RB to_TO its_PRP$ introduction_NN into_IN
          mouse_NN ES_NNP cells_NNS by_IN electroporation_NN ._. The_DT γ_NN 
          1_CD gene_NN contains_VBZ 4_CD exons_NNS ,_, and_CC correct_JJ
          targeting_VBG results_NNS in_IN the_DT deletion_NN of_IN all_DT 4_CD exons_NNS ,_, which_WDT
          will_MD inactivate_NN the_DT gene_NN (_( Fig_NNP ._. 1_LS Aiii_NNP )_) ._. Probe_NNP 2_CD was_VBD used_VBN
          for_IN identification_NN of_IN targeted_VBN clones_NNS [_NN 41_CD ]_NN ._. 5_LS μg_NN of_IN the_DT
          targeting_VBG vector_NN was_VBD electroporated_JJ into_IN 5_CD ×_NN 10_CD 6_CD AB_NNP 1_CD ES_NNP
          cells_NNS ._. G_NNP 418_CD and_CC FIAU_NNP
          (_( 1_CD -_: (_( 2_CD '_POS -_: deoxy-_NN 2_CD '_POS -_: fluoro-γ-_JJ D-_NNP arabinofuranosyl_NN )_) -_: 5_CD -_: iodouracil_NN )_)
          resistant_JJ clones_NNS were_VBD analyzed_VBN by_IN Southern_NNP blotting_VBG after_IN
          digestion_NN with_IN either_DT 
          Eco_NNP RI_NNP and_CC hybridization_NN to_TO probe_NN 1_CD
          or_CC digestion_NN with_IN 
          Hind_NNP III_NNP and_CC hybridization_NN to_TO probe_VB
          2_CD (_( Fig_NNP ._. 1_LS )_) ._. Of_IN three_CD clones_NNS targeted_VBN on_IN the_DT 5_CD '_POS end_NN ,_, two_CD
          also_RB were_VBD targeted_VBN on_IN the_DT 3_CD '_POS end_NN ._. These_DT were_VBD expanded_VBN and_CC
          used_VBN to_TO produce_VB germline_NN chimeras_NNS ._. Mice_NNS homozygous_JJ for_IN
          the_DT targeted_VBN allele_NN were_VBD viable_JJ ,_, with_IN no_DT apparent_JJ
          abnormalities_NNS ._. Mice_NNS heterozygous_JJ and_CC homozygous_JJ for_IN the_DT
          targeted_VBN mutation_NN are_VBP referred_VBN to_TO as_IN γ_NN 
          1_CD het_NN and_CC γ_NN 
          1_CD null_NN ,_, respectively_RB ._.
        
        
          Western_JJ blots_NNS
          Total_JJ microsomes_NNS were_VBD prepared_VBN from_IN the_DT forelimb_NN and_CC
          hind_NN limb_NN muscles_NNS of_IN control_NN ,_, γ_NN 
          1_CD het_NN ,_, and_CC γ_NN 
          1_CD null_NN adult_NN mice_NNS as_RB previously_RB
          described_VBD [_NN 42_CD ]_NN ._. Total_JJ microsomes_NNS were_VBD washed_VBN twice_RB with_IN
          0_CD ._. 6_CD M_NNP KCl_NNP buffer_NN and_CC 100_CD μg_NN of_IN total_JJ membrane_NN protein_NN was_VBD
          applied_VBN to_TO a_DT 5_CD -_: 15_CD %_NN SDS_NNP polyacrylamide_NN gel_NN ._. Proteins_NNPS were_VBD
          transferred_VBN to_TO PVDF_NNP membranes_NNS and_CC analyzed_VBD with_IN either_DT
          anti-α_JJ 
          1_CD S_NNP mAb_NN IIC_NNP 12_CD antibody_NN [_NN 43_CD ]_NN ,_, or_CC anti-α_JJ
          
          2_LS -_: δ_NN protein_NN G-_NNP purified_JJ guinea_NN pig_NN
          antibody_NN #_# 1_CD [_NN 13_CD ]_NN ,_, or_CC anti-β_JJ 
          1_CD a_DT affinity-purified_JJ sheep_NN #_# 6_CD antibody_NN
          [_NN 44_CD ]_NN ,_, or_CC with_IN anti-γ_JJ 
          1_CD affinity-purified_JJ guinea_NN pig_NN #_# 16_CD
          antibody_NN and_CC the_DT appropriate_JJ secondary_JJ antibodies_NNS [_NN 11_CD ]_NN ._.
          The_DT subunits_NNS were_VBD visualized_JJ using_VBG SuperSignal_NNP ECL_NNP
          reagent_NN (_( Pierce_NNP ,_, Rockford_NNP ,_, IL_NNP )_) ._. The_DT images_NNS were_VBD captured_VBN
          on_IN a_DT Chemi-_NNP Imager_NNP (_( Alpha_NNP Innotech_NNP ,_, San_NNP Leandro_NNP ,_, CA_NNP )_) set_VBN
          to_TO a_DT level_NN just_RB below_IN saturation_NN ._.
        
        
          Primary_JJ cultures_NNS of_IN mouse_NN myotubes_NNS
          Primary_JJ cultures_NNS were_VBD prepared_VBN from_IN hind_NN limbs_NNS of_IN day_NN
          18_CD embryos_NNS (_( E_NNP 18_CD )_) as_IN described_VBN previously_RB [_NN 45_CD ]_NN ._. Dissected_NNP
          muscles_NNS were_VBD incubated_JJ for_IN 9_CD min_NN at_IN 37_CD °_NN C_NNP in_IN Ca_MD 2_CD +_NN /_NN Mg_NNP
          2_CD +_NN -_: free_JJ Hanks_NNP balanced_JJ salt_NN solution_NN (_( in_IN mM_NN :_: 136_CD ._. 9_CD NaCl_NNP ,_,
          3_CD KCl_NNP ,_, 0_CD ._. 44_CD KH_NNP 
          2_CD PO_NNP 
          4_CD ,_, 0_CD ._. 34_CD NaHPO_NNP 
          4_CD ,_, 4_CD ._. 2_CD NaHCO_NNP 
          3_CD ,_, 5_CD ._. 5_CD glucose_NN ,_, pH_NN 7_CD ._. 2_LS )_) containing_VBG
          0_CD ._. 25_CD %_NN (_( w_NN /_NN v_NN )_) trypsin_NN and_CC 0_CD ._. 05_CD %_NN (_( w_NN /_NN v_NN )_) pancreatin_NN (_( Sigma_NNP ,_,
          St_NNP ._. Louis_NNP ,_, MO_NNP )_) ._. Mononucleated_NNP cells_NNS were_VBD resuspended_JJ in_IN
          plating_VBG medium_NN containing_VBG 78_CD %_NN Dulbecco_NNP 's_POS modified_VBN Eagle_NNP 's_POS
          medium_NN (_( DMEM_NNP )_) with_IN low_JJ glucose_NN (_( Life_NNP Technologies_NNPS ,_,
          Rockville_NNP ,_, MD_NNP )_) ,_, 10_CD %_NN horse_NN serum_NN (_( HS_NNP ,_, Sigma_NNP ,_, St_NNP ._. Louis_NNP ,_,
          MO_NNP )_) ,_, 10_CD %_NN fetal_JJ bovine_JJ serum_NN (_( FBS_NNP ,_, Sigma_NNP ,_, St_NNP ._. Louis_NNP ,_, MO_NNP )_) ,_,
          2_CD %_NN chicken_NN embryo_NN extract_NN (_( CEE_NNP ,_, Life_NNP Technologies_NNPS ,_,
          Rockville_NNP ,_, MD_NNP )_) and_CC plated_JJ on_IN plastic_NN culture_NN dishes_NNS
          coated_VBN with_IN gelatin_NN at_IN a_DT density_NN of_IN ∼_NN 1_CD ×_NN 10_CD 4_CD cells_NNS per_IN
          dish_NN ._. Cultures_NNP were_VBD grown_VBN at_IN 37_CD °_NN C_NNP in_IN 8_CD %_NN CO_NNP 
          2_CD ._. After_IN the_DT fusion_NN of_IN myoblasts_NNS (_( ∼_NN 7_CD
          days_NNS )_) ,_, the_DT medium_NN was_VBD replaced_VBN with_IN a_DT FBS-free_NNP medium_NN
          (_( 88_CD ._. 75_CD %_NN DMEM_NNP ,_, 10_CD %_NN HS_NNP ,_, 1_CD ._. 25_CD %_NN CEE_NNP )_) and_CC cells_NNS were_VBD
          incubated_JJ in_IN 5_CD %_NN CO_NNP 
          2_CD ._. All_DT media_NNS contained_VBD 0_CD ._. 1_CD %_NN v_NN /_NN v_NN
          penicillin_NN and_CC streptomycin_NN (_( Sigma_NNP ,_, St_NNP ._. Louis_NNP ,_, MO_NNP )_) ._. All_DT
          measurements_NNS were_VBD made_VBN when_WRB the_DT cells_NNS had_VBD been_VBN in_IN culture_NN
          for_IN 7_CD -_: 10_CD days_NNS ._. During_IN this_DT time_NN the_DT maximal_NN current_JJ
          density_NN did_VBD not_RB change_VB [_NN 45_CD ]_NN ._.
        
        
          Electrophysiological_NNP measurements_NNS
          Whole-cell_NNP recordings_NNS were_VBD performed_VBN as_IN described_VBN
          previously_RB [_NN 29_CD ]_NN using_VBG an_DT Axopatch_NNP 200_CD B_NNP amplifier_NN (_( Axon_NNP
          Instruments_NNP ,_, Foster_NNP City_NNP ,_, CA_NNP )_) ._. Linear_NNP capacity_NN and_CC leak_NN
          currents_NNS were_VBD compensated_VBN with_IN the_DT circuit_NN provided_VBN by_IN
          the_DT manufacturer_NN ._. Series_NN resistance_NN ,_, Rs_NNP ,_, was_VBD compensated_VBN
          up_RP to_TO the_DT point_NN of_IN amplifier_NN oscillation_NN with_IN the_DT
          Axopatch_NNP circuit_NN ._. Considering_VBG all_DT cells_NNS in_IN the_DT present_JJ
          study_NN ,_, the_DT linear_JJ capacitance_NN (_( mean_VB ±_NN SE_NNP )_) of_IN control_NN ,_, γ_NN 
          1_CD null_NN ,_, and_CC γ_NN 
          1_CD het_NN myotubes_NNS was_VBD 256_CD ±_NN 25_CD pF_NN (_( 38_CD
          cells_NNS )_) ,_, 246_CD ±_NN 16_CD pF_NN (_( 34_CD cells_NNS )_) and_CC 223_CD ±_NN 24_CD (_( 23_CD cells_NNS )_) ,_,
          respectively_RB ._. Rs_NNP of_IN the_DT same_JJ cells_NNS before_IN analog_NN
          compensation_NN was_VBD 7_CD ±_NN 0_CD ._. 5_CD MΩ_NNP ,_, 7_CD ._. 2_CD ±_NN 0_CD ._. 4_CD MΩ_NNP ,_, and_CC 6_CD ._. 3_CD ±_NN 0_CD ._. 5_CD
          MΩ_NNP ,_, respectively_RB ._. Following_VBG compensation_NN ,_, the_DT effective_JJ
          Rs_NNP was_VBD <_NN 2_CD MΩ_NNP in_IN all_DT cases_NNS measured_VBN ,_, although_IN this_DT was_VBD
          not_RB measured_VBN systematically_RB ._. Considering_VBG a_DT mean_JJ cell_NN
          capacitance_NN of_IN 240_CD pF_NN ,_, a_DT typical_JJ maximum_NN current_JJ density_NN
          of_IN 5_CD to_TO 10_CD pA_NN /_NN pF_NN (_( see_VB Fig_NNP ._. 3_LS B_NNP )_) ,_, and_CC Rs_NNP (_( effective_JJ )_) <_NN 2_CD
          MΩ_NNP ,_, the_DT voltage_NN error_NN was_VBD <_NN 2_CD ._. 4_LS to_TO <_NN 4_CD ._. 8_CD mV_NN ._. All_DT
          experiments_NNS were_VBD performed_VBN at_IN room_NN temperature_NN ._. Patch_NNP
          pipettes_NNS had_VBD an_DT open_JJ tip_NN resistance_NN of_IN 1_CD -_: 2_CD MΩ_NNP when_WRB filled_VBN
          with_IN the_DT pipette_NN solution_NN ._. Ca_MD 2_CD +_NN currents_NNS were_VBD measured_VBN
          from_IN a_DT holding_VBG potential_NN of_IN -_: 40_CD mV_NN ._. Test_NN pulses_NNS of_IN 500_CD ms_NNS
          in_IN 5_CD mV_NN increments_NNS ranged_VBD from_IN -_: 40_CD mV_NN to_TO +_NN 60_CD mV_NN ._. Ca_MD
          2_CD +_NN conductance_NN vs_NNS ._. voltage_NN curves_NNS were_VBD obtained_VBN by_IN
          extrapolation_NN of_IN the_DT Ca_MD 2_CD +_NN current_JJ to_TO the_DT reversal_NN
          potential_NN of_IN the_DT cell_NN ._. To_TO measure_VB inactivation_NN ,_, cells_NNS
          were_VBD held_VBN at_IN -_: 80_CD mV_NN ,_, then_RB stepped_VBD to_TO a_DT series_NN of_IN
          depolarizing_VBG (_( pre-pulse_JJ )_) voltages_NNS ,_, from_IN -_: 70_CD mV_NN to_TO +_NN 70_CD mV_NN
          in_IN 10_CD mV_NN increments_NNS ,_, for_IN 2_CD ._. 5_CD seconds_NNS to_TO promote_VB
          inactivation_NN ,_, then_RB stepped_VBD to_TO -_: 50_CD mV_NN for_IN 100_CD ms_NNS to_TO close_VB
          non-inactivated_JJ channels_NNS ,_, then_RB stepped_VBD for_IN 200_CD ms_NNS to_TO the_DT
          test_NN potential_NN of_IN +_NN 20_CD mV_NN to_TO measure_VB Ca_MD 2_CD +_NN currents_NNS ,_, then_RB
          stepped_VBD to_TO the_DT -_: 80_CD mV_NN holding_VBG potential_JJ for_IN 5_CD seconds_NNS to_TO
          permit_VB recovery_NN from_IN inactivation_NN ._. Charge_VB movement_NN was_VBD
          measured_VBN using_VBG a_DT protocol_NN that_WDT eliminated_VBD
          immobilization-sensitive_JJ components_NNS [_NN 15_CD ,_, 28_CD ,_, 29_CD ]_NN ._.
          Voltage_NNP was_VBD stepped_VBN from_IN a_DT holding_VBG potential_NN of_IN -_: 80_CD mV_NN to_TO
          -_: 35_CD mV_NN for_IN 750_CD ms_NNS ,_, then_RB to_TO -_: 50_CD mV_NN for_IN 5_CD ms_NNS ,_, then_RB to_TO test_VB
          potential_JJ for_IN 25_CD ms_NNS ,_, then_RB to_TO -_: 50_CD mV_NN for_IN 30_CD ms_NNS and_CC finally_RB
          to_TO the_DT -_: 80_CD mV_NN holding_VBG potential_JJ ._. Subtraction_NNP of_IN the_DT
          linear_JJ component_NN was_VBD assisted_VBN by_IN a_DT P_NN /_NN 4_CD procedure_NN
          following_VBG the_DT pulse_NN paradigm_NN listed_VBN above_IN ._. P_NN /_NN 4_CD pulses_NNS
          were_VBD separated_VBN by_IN 500_CD ms_NNS and_CC had_VBD a_DT duration_NN of_IN 25_CD ms_NNS ._.
          Previous_JJ studies_NNS showed_VBD this_DT choice_NN of_IN pulse_NN protocol_NN and_CC
          internal_JJ and_CC external_JJ solutions_NNS resulted_VBD in_IN
          nifedipine-sensitive_JJ charge_NN movements_NNS of_IN a_DT magnitude_NN ∼_NN 5_CD
          fold_VB larger_JJR than_IN those_DT detected_VBN in_IN dysgenic_JJ myotubes_NNS
          lacking_VBG α_NN 
          1_CD S_NNP [_NN 29_CD ]_NN ._.
        
        
          Solutions_NNPS
          The_DT external_JJ solution_NN in_IN all_DT cases_NNS was_VBD (_( in_IN mM_NN )_) 130_CD TEA_NNP
          methanesulfonate_NN ,_, 10_CD CaCl_NNP 
          2_CD ,_, 1_CD MgCl_NNP 
          2_CD ,_, 10_CD HEPES_NNP titrated_JJ with_IN TEA_NNP (_( OH_NNP )_) to_TO
          pH_NN 7_CD ._. 4_CD ._. For_IN Ca_MD 2_CD +_NN transients_NNS and_CC Ca_MD 2_CD +_NN currents_NNS ,_, the_DT
          pipette_NN solution_NN was_VBD (_( in_IN mM_NN )_) 140_CD Ca_MD 2_CD +_NN -_: Aspartate_NNP ,_, 5_CD MgCl_NNP 
          2_CD ,_, 0_CD ._. 1_CD EGTA_NNP (_( Ca_MD 2_CD +_NN transients_NNS )_) or_CC 5_CD mM_NN
          EGTA_NNP (_( Ca_MD 2_CD +_NN currents_NNS )_) ,_, and_CC 10_CD MOPS-CsOH_NNP pH_NN 7_CD ._. 2_CD ._. For_IN charge_NN
          movements_NNS ,_, the_DT pipette_NN solution_NN was_VBD (_( in_IN mM_NN )_) 120_CD NMG_NNP
          (_( N-_NNP methyl_NN glucamine_NN )_) -_: Glutamate_NNP ,_, 10_CD HEPES-NMG_NNP ,_, 10_CD EGTA-NMG_NNP
          pH_NN 7_CD ._. 3_CD ._. For_IN charge_NN movements_NNS ,_, the_DT external_JJ solution_NN was_VBD
          supplemented_JJ with_IN 0_CD ._. 5_CD mM_NN CdCl_NNP 
          2_CD and_CC 0_CD ._. 5_CD mM_NN LaCl_NNP 
          3_CD to_TO block_VB the_DT Ca_MD 2_CD +_NN current_JJ and_CC 0_CD ._. 05_CD
          mM_NN TTX_NNP to_TO block_VB residual_JJ Na_NNP +_NN current_JJ ._.
        
        
          Ca_MD 2_CD +_NN transient_JJ measurements_NNS
          Ca_MD 2_CD +_NN transients_NNS were_VBD measured_VBN using_VBG a_DT confocal_NN
          microscope_NN in_IN line-scan_JJ mode_NN as_IN described_VBN previously_RB [_NN
          46_CD ,_, 47_CD ,_, 48_CD ]_NN ._. Cells_NNP were_VBD loaded_VBN with_IN 4_CD mM_NN fluo-_NN 4_CD (_( fluo-_NN 4_CD
          acetoxymethyl_NN (_( AM_NNP )_) ester_NN ,_, Molecular_NNP Probes_NNP ,_, Eugene_NNP ,_, OR_NNP )_)
          for_IN 20_CD to_TO 40_CD min_NN at_IN room_NN temperature_NN ._. Stocks_NNS of_IN fluo-_NN 4_CD (_( 1_CD
          mg_NN /_NN ml_NN )_) were_VBD made_VBN in_IN DMSO_NNP and_CC stored_VBD frozen_VBN ._. All_DT
          experiments_NNS were_VBD performed_VBN at_IN room_NN temperature_NN ._. Cells_NNP
          were_VBD viewed_VBN with_IN an_DT inverted_JJ Olympus_NNP microscope_NN with_IN a_DT
          20_CD X_NNP objective_NN (_( N_NNP ._. A_DT ._. =_SYM 0_CD ._. 4_LS )_) and_CC a_DT Fluoview_NNP confocal_NN
          attachment_NN (_( Olympus_NNP ,_, Melville_NNP ,_, NY_NNP )_) ._. The_DT 488_CD nm_NN spectrum_NN
          line_NN necessary_JJ for_IN fluo-_NN 4_CD excitation_NN was_VBD provided_VBN by_IN a_DT 5_CD
          mW_NN argon_NN laser_NN attenuated_JJ to_TO 20_CD %_NN with_IN neutral_JJ density_NN
          filters_NNS ._. The_DT fluorescence_NN intensity_NN ,_, F_NN ,_, was_VBD calculated_VBN by_IN
          densitometric_JJ scanning_VBG of_IN line-scan_JJ images_NNS and_CC was_VBD
          averaged_VBN over_IN the_DT entire_JJ width_NN of_IN the_DT cell_NN ._. The_DT
          background_NN fluorescence_NN intensity_NN (_( Fo_NNP )_) was_VBD averaged_VBN in_IN
          the_DT same_JJ manner_NN from_IN areas_NNS of_IN the_DT same_JJ image_NN prior_RB to_TO the_DT
          voltage_NN pulse_NN ._. The_DT fluorescence_NN unit_NN ΔF_NN /_NN Fo_NNP corresponds_NNS to_TO
          (_( F-F_NNP o_NN )_) /_NN Fo_NNP ._. The_DT limit_NN of_IN fluorescence_NN detection_NN ,_, based_VBN on_IN
          microscope_NN settings_NNS and_CC the_DT average_JJ resting_VBG fluo-_NN 4_CD
          fluorescence_NN ,_, was_VBD ∼_NN 0_CD ._. 1_CD ΔF_NN /_NN Fo_NNP units_NNS ._. That_DT is_VBZ ,_, we_PRP could_MD
          detect_VB a_DT ∼_NN 10_CD %_NN change_NN above_IN the_DT cell_NN resting_VBG
          fluorescence_NN ._. Using_VBG a_DT pseudo-ratiometric_JJ equation_NN for_IN
          estimating_VBG the_DT cytosolic_JJ free_JJ Ca_MD 2_CD +_NN [_NN 48_CD ]_NN and_CC assuming_VBG a_DT
          resting_VBG free_JJ Ca_MD 2_CD +_NN of_IN 100_CD nM_NN [_NN 48_CD ]_NN ,_, the_DT nominal_JJ limit_NN of_IN
          resolution_NN of_IN free_JJ Ca_MD 2_CD +_NN change_NN was_VBD ∼_NN 200_CD nM_NN ._.
        
        
          Data_NNP and_CC error_NN analysis_NN
          For_IN each_DT cell_NN ,_, or_CC for_IN the_DT population_NN average_NN ,_, the_DT
          voltage_NN dependence_NN of_IN charge_NN movements_NNS (_( Q_NNP )_) ,_, Ca_MD
          2_CD +_NN conductance_NN (_( G_NNP )_) ,_, and_CC peak_NN intracellular_NN Ca_MD 2_CD +_NN (_( ΔF_NN /_NN Fo_NNP )_)
          were_VBD fitted_JJ according_VBG to_TO a_DT Boltzmann_NNP equation_NN A_DT =_SYM A_DT 
          max_NN /_NN (_( 1_CD +_NN exp_NN (_( -_: (_( V-V_NNP 
          1_CD /_NN 2_LS )_) /_NN k_NN )_) )_) where_WRB A_DT 
          max_NN was_VBD either_CC Q_NNP 
          max_NN ,_, G_NNP 
          max_NN or_CC ΔF_NN /_NN Fo_NNP 
          max_NN ;_: V_NNP 
          1_CD /_NN 2_CD is_VBZ the_DT potential_NN at_IN which_WDT A_DT =_SYM A_DT 
          max_NN /_NN 2_CD ;_: and_CC k_NN is_VBZ the_DT slope_NN factor_NN ._. For_IN
          a_DT fit_NN of_IN steady-state_JJ inactivation_NN ,_, the_DT term_NN (_( V-V_NNP 
          1_CD /_NN 2_LS )_) in_IN the_DT equation_NN above_IN was_VBD
          replaced_VBN by_IN (_( V_NNP 
          1_CD /_NN 2_CD -_: V_NNP )_) ._. Ca_MD 2_CD +_NN conductance_NN for_IN each_DT
          cell_NN was_VBD computed_JJ from_IN the_DT extrapolated_VBN reversal_NN
          potential_JJ and_CC the_DT maximal_NN Ca_MD 2_CD +_NN current_JJ at_IN each_DT voltage_NN ._.
          In_IN all_DT figures_NNS ,_, the_DT symbols_NNS and_CC error_NN bars_NNS correspond_VB to_TO
          the_DT population_NN mean_NN ±_NN 1_CD SEM_NNP ._. The_DT curves_NNS correspond_VB to_TO a_DT
          Boltzmann_NNP fit_NN of_IN the_DT mean_NN ._. In_IN addition_NN to_TO Student_NNP t-tests_JJ
          reported_VBD in_IN Table_NNP 1_CD ,_, one-way_JJ ANOVA_NNP tests_NNS were_VBD conducted_VBN
          among_IN the_DT 11_CD sets_NNS of_IN Boltzmann_NNP parameters_NNS of_IN control_NN ,_, γ_NN 
          1_CD het_NN and_CC γ_NN 
          1_CD null_NN cells_NNS of_IN Table_NNP 1_CD ._. The_DT null_NN
          hypothesis_NNS (_( equality_NN of_IN means_NNS )_) was_VBD not_RB rejected_VBN at_IN a_DT
          level_NN of_IN significance_NN p_NN <_NN 0_CD ._. 05_CD except_IN in_IN the_DT two_CD cases_NNS
          also_RB identified_VBN by_IN t-tests_JJ ,_, namely_RB G_NNP 
          max_NN and_CC V_NNP 
          1_CD /_NN 2_CD inactivation_NN ._. An_DT F-_NNP test_NN ,_, which_WDT
          formally_RB tests_VBZ for_IN the_DT difference_NN between_IN the_DT variances_NNS
          of_IN independent_JJ populations_NNS ,_, was_VBD used_VBN to_TO determine_VB which_WDT
          of_IN the_DT fitted_JJ Boltzmann_NNP parameters_NNS (_( A_DT 
          max_NN ,_, V_NNP 
          1_CD /_NN 2_CD ,_, k_NN )_) had_VBD the_DT largest_JJS variance_NN ,_, and_CC
          thus_RB the_DT largest_JJS experimental_JJ error_NN ._. The_DT ranking_JJ order_NN in_IN
          variance_NN error_NN was_VBD V_NNP 
          1_CD /_NN 2_CD >_NN A_DT 
          max_NN >_NN k_NN ._. Furthermore_RB ,_, the_DT error_NN in_IN V_NNP
          
          1_LS /_NN 2_CD was_VBD the_DT largest_JJS for_IN the_DT
          fluorescence_NN measurement_NN and_CC the_DT smallest_JJS for_IN the_DT
          conductance_NN measurement_NN ._. This_DT result_NN was_VBD expected_VBN since_IN
          the_DT size_NN of_IN the_DT voltage_NN step_NN used_VBN in_IN the_DT V_NNP 
          1_CD /_NN 2_CD determination_NN was_VBD 5_CD mV_NN for_IN
          conductance_NN ,_, 10_CD mV_NN for_IN charge_NN movements_NNS ,_, and_CC 20_CD mV_NN for_IN
          fluorescence_NN ._. The_DT number_NN of_IN voltage_NN steps_NNS in_IN fluorescence_NN
          measurements_NNS was_VBD kept_VBN to_TO a_DT minimum_NN to_TO avoid_VB rundown_NN of_IN
          the_DT Ca_MD 2_CD +_NN transient_JJ due_NN to_TO photobleaching_VBG ._. The_DT limit_NN of_IN
          resolution_NN of_IN V_NNP 
          1_CD /_NN 2_CD ,_, the_DT parameter_NN with_IN the_DT largest_JJS
          error_NN ,_, was_VBD estimated_VBN with_IN a_DT z-test_JJ which_WDT formally_RB tests_VBZ
          for_IN the_DT difference_NN between_IN the_DT mean_NN of_IN a_DT population_NN and_CC a_DT
          hypothetical_JJ mean_NN ._. We_PRP determined_VBD the_DT smallest_JJS difference_NN
          between_IN a_DT experimental_JJ and_CC a_DT hypothesized_VBN V_NNP 
          1_CD /_NN 2_CD resolvable_JJ at_IN a_DT level_NN of_IN
          statistical_JJ confidence_NN p_NN <_NN 0_CD ._. 05_CD ._. In_IN the_DT calculations_NNS ,_, we_PRP
          used_VBD the_DT data_NNS with_IN the_DT largest_JJS V_NNP 
          1_CD /_NN 2_CD variance_NN for_IN each_DT measurement_NN
          (_( conductance_NN ,_, charge_NN movement_NN and_CC fluorescence_NN )_) ._. Also_RB ,_, we_PRP
          assumed_VBD a_DT hypothetical_JJ S_NNP ._. D_NNP ._. equal_JJ to_TO the_DT experimental_JJ
          S_NNP ._. D_NNP ._. The_DT estimated_VBN limits_NNS of_IN statistical_JJ resolution_NN were_VBD
          ∼_NN 3_CD ._. 9_CD mV_NN for_IN conductance_NN ,_, ∼_NN 6_CD ._. 5_CD mV_NN for_IN charge_NN movements_NNS ,_,
          and_CC ∼_NN 8_CD ._. 5_CD mV_NN for_IN fluorescence_NN measurements_NNS ._. Thus_RB ,_, a_DT
          difference_NN in_IN population_NN mean_NN V_NNP 
          1_CD /_NN 2_CD of_IN less_JJR than_IN the_DT indicated_VBN limit_NN
          would_MD not_RB be_VB statistically_RB significant_JJ ,_, given_VBN the_DT
          variance_NN and_CC the_DT number_NN of_IN determinations_NNS of_IN the_DT present_JJ
          study_NN ._. Statistical_NNP analyses_NNS were_VBD performed_VBN with_IN
          Analyse-it_NNP software_NN (_( Leeds_NNP ,_, UK_NNP )_)
        
      
      
        List_NN of_IN Abbreviations_NNP
        AID_NNP (_( α_NN subunit_NN interaction_NN domain_NN )_) ;_: BID_NNP (_( β_NN subunit_NN
        interaction_NN domain_NN )_) ;_: DMSO_NNP (_( dimethyl_NN sulfoxide_NN )_) ;_: EGTA_NNP
        (_( ethylene_NN glycol_NN bis-aminoethylether_JJ tetraacetic_JJ acid_NN )_) ;_:
        HEPES_NNP (_( 2_CD -_: hydroxylethyl_NN piperazine_NN 2_CD -_: ethane_NN sulfonic_JJ acid_NN )_) ;_:
        MOPS_NNP (_( 3_CD N-M_NNP orpholino-propane_JJ sulfonic_JJ acid_NN )_) ;_: PVDF_NNP
        (_( polyvinylidene_NN difluoride_NN )_) ;_: TTX_NNP (_( tetrodotoxin_NN )_) ;_: TEA_NNP
        (_( tetraethylamonium_NN )_) ._.
      
    
  
